CeeMCee Pharma Consulting
ActiveSummary
CeeMCee Pharma Consulting has been active since 2013 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €237,984 and a net result of €62,418. Equity is growing by about 27% per year across the filed financial years. Its solvency ranks better than 75% of 613 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Articles of association
What the company does
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- CeeMCee Pharma Consulting
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Vlaams Gewest” (deed in Dutch)
Who represents it, and how
- Who signsWho may bind the company towards others, for example by signing a contract.
- Each director alone
- Board ruleHow the board is made up, meets and takes decisions.
- “Behalve deze die wet of statuten aan algemene vergadering voorbehouden, geheel van bevoegdheden aan hem toegekend met mogelijkheid deel te…” (deed in Dutch)1 more provision on this in the deed
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- Last Friday of April at 18:00